Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications

Details for Australian Patent Application No. 2006216646 (hide)

Owner Prexa Pharmaceuticals, Inc.

Inventors Hauske, James R.

Agent Shelston IP

Pub. Number AU-B-2006216646

PCT Pub. Number WO2006/091697

Priority 60/655,978 23.02.05 US

Filing date 21 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 31 May 2012

International Classifications

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091697 Priority application(s): WO2006/091697

5 June 2008 Assignment before Grant

  Psychenomics, Inc. The application has been assigned to Prexa Pharmaceuticals, Inc.

31 May 2012 Application Accepted

  Published as AU-B-2006216646

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216649-Method and apparatus for stimulating wells with propellants

2006216645-Biological specimen container cap with actuated access